Analyst Ratings
The North American stock market outlook for today is selective by sector. Technology and semiconductors retain support from AI investment, while Canadian materials and miners benefit from a rebound in gold and copper; both areas remain sensitive to elevated bond yields. Energy has positive analyst support in Canada, but weaker crude prices are weighing on near-term trading. Industrials present a mixed picture as target increases sit alongside cuts, while higher borrowing costs warrant caution in real estate and other rate-sensitive stocks. Consumer sectors face pressure from weaker U.S. confidence, and financials may remain sensitive to the path of interest rates and economic growth. Overall, the stronger opportunities appear concentrated in companies with clear earnings catalysts rather than a broad market advance.
Canadian Analyst Updates (40)
Alaris Equity Partners Income Trust (AD.UN:CA) — Canaccord Genuity maintained its Buy rating and raised its price target to C$30.25 from C$30.00.
Alaris Equity Partners Income Trust (AD.UN:CA) — Desjardins Securities maintained its Buy rating and raised its price target to C$28.00 from C$27.50.
Alaris Equity Partners Income Trust (AD.UN:CA) — National Bank maintained its Outperform rating and raised its price target to C$31.50 from C$30.50.
Alaris Equity Partners Income Trust (AD.UN:CA) — Stifel Nicolaus maintained its Buy rating and raised its price target to C$27.00 from C$26.00.
Aritzia Inc. (ATZ:CA) — Ventum Capital maintained its Neutral rating and lowered its price target to C$146.00 from C$186.00.
B2Gold Corp. (BTO:CA) — Scotiabank maintained its Sector Perform rating and C$10.00 price target.
Barksdale Resources Corp. (BRO:CA) — ATB Cormark upgraded the stock to Speculative Buy and raised its price target to C$0.30 from C$0.25.
Baytex Energy Corp. (BTE:CA) — National Bank maintained its Outperform rating and raised its price target to C$9.50 from C$8.50.
Cascades Inc. (CAS:CA) — CIBC maintained its Outperform rating and raised its price target to C$23.00 from C$17.50.
Cenovus Energy Inc. (CVE:CA) — National Bank maintained its Outperform rating and set a C$60.00 price target.
Discovery Mining Ltd. (DSV:CA) — Raymond James maintained its Outperform rating and raised its price target to C$15.00 from C$11.50.
Dye & Durham Ltd. (DND:CA) — CIBC maintained its Neutral rating and C$2.50 price target.
Finning International Inc. (FTT:CA) — Stifel Nicolaus maintained its Buy rating and set a C$127.00 price target.
Fortis Inc. (FTS:CA) — Barclays maintained its Overweight rating and lowered its price target to C$76.00 from C$82.00.
Hudbay Minerals Inc. (HBM:CA) — Scotiabank maintained its Sector Perform rating and C$43.00 price target.
Kelt Exploration Ltd. (KEL:CA) — National Bank maintained its Outperform rating and set a C$13.25 price target.
Logan Energy Corp. (LGN:CA) — National Bank maintained its Outperform rating and set a C$1.75 price target.
Montage Gold Corp. (MAU:CA) — Scotiabank maintained its Sector Perform rating and C$20.00 price target.
Osisko Metals Incorporated (OM:CA) — Scotiabank maintained its Sector Perform rating and C$3.00 price target.
Ovintiv Inc. (OVV:CA) — National Bank maintained its Outperform rating and raised its price target to C$129.00 from C$118.00.
Perpetua Resources Corp. (PPTA) — Scotiabank maintained its Sector Perform rating and set a C$55.00 price target.
Sangoma Technologies Corp. (STC:CA) — Acumen Capital lowered its price target to C$7.40 from C$11.00 and assigned a Tender rating.
Sangoma Technologies Corp. (STC:CA) — TD Securities downgraded the stock to Sell and lowered its price target to C$7.35 from C$8.00.
Slate Grocery REIT (SGR.U) — Scotiabank maintained its Sector Perform rating and US$13.00 price target.
Slate Grocery REIT (SGR.UN:CA) — ATB Cormark raised its price target to C$13.00 from C$8.00 and assigned a Tender rating.
Slate Grocery REIT (SGR.UN:CA) — TD Securities downgraded the stock to Sell and raised its price target to C$13.00 from C$12.00.
Strathcona Resources Ltd. (SCR:CA) — National Bank maintained its Outperform rating and lowered its price target to C$63.00 from C$67.00.
Suncor Energy Inc. (SU:CA) — National Bank maintained its Outperform rating and raised its price target to C$146.00 from C$118.00.
TC Energy Corp. (TRP:CA) — CIBC maintained its Outperform rating and C$103.00 price target.
TC Energy Corp. (TRP:CA) — TD Securities maintained its Buy rating and C$102.00 price target.
Tenaz Energy Corp. (TNZ:CA) — National Bank maintained its Outperform rating and raised its price target to C$100.00 from C$91.00.
Thesis Gold & Silver Inc. (TAU:CA) — Scotiabank maintained its Sector Perform rating and C$5.50 price target.
Toromont Industries Ltd. (TIH:CA) — Stifel Nicolaus maintained its Buy rating and C$250.00 price target.
Wajax Corp. (WJX:CA) — Stifel Nicolaus maintained its Buy rating and C$45.00 price target.
Whitecap Resources Inc. (WCP:CA) — National Bank maintained its Outperform rating and raised its price target to C$27.00 from C$26.00.
WSP-Global Inc. (WSP:CA) — BMO maintained its Outperform rating and lowered its price target to C$275.00 from C$280.00.
WSP-Global Inc. (WSP:CA) — National Bank maintained its Outperform rating and lowered its price target to C$216.00 from C$219.00.
WSP-Global Inc. (WSP:CA) — RBC Capital maintained its Outperform rating and lowered its price target to C$303.00 from C$304.00.
WSP-Global Inc. (WSP:CA) — Stifel Nicolaus maintained its Buy rating and lowered its price target to C$230.00 from C$280.00.
WSP-Global Inc. (WSP:CA) — TD Securities maintained its Buy rating and C$255.00 price target.
Yangarra Resources Ltd. (YGR:CA) — ATB Cormark maintained its Outperform rating and raised its price target to C$2.20 from C$1.80.
U.S. Analyst Updates (242)
10x Genomics (TXG) — Leerink Partners raised its price target to $90.00 from $40.00 and maintained its Market Perform rating.
4D Molecular Therapeutics (FDMT) — Bank of America raised its price target to $33.00 from $29.00 and maintained its Buy rating.
AAR (AIR) — Guggenheim reiterated its Neutral rating.
AbCellera Biologics (ABCL) — JPMorgan initiated coverage with an Overweight rating and set a $17.00 price target.
Acuity (AYI) — Robert W. Baird lowered its price target to $360.00 from $390.00 and maintained its Neutral rating.
Adaptive Biotechnologies (ADPT) — Goldman Sachs Group initiated coverage with a Buy rating and set a $35.00 price target.
Adeia (ADEA) — Rosenblatt Securities reiterated its Buy rating and set a $40.00 price target.
Adicet Bio (ACET) — Benchmark reiterated its Buy rating.
Advanced Micro Devices (AMD) — Rosenblatt Securities reiterated its Buy rating and set a $700.00 price target.
Affiliated Managers Group (AMG) — TD Cowen reiterated its Buy rating and set a $512.00 price target.
Akamai Technologies (AKAM) — Raymond James Financial reiterated its Outperform rating and set a $170.00 price target.
Aldeyra Therapeutics (ALDX) — BTIG Research reiterated its Buy rating.
Ameren (AEE) — Scotiabank initiated coverage with a Sector Perform rating and set a $104.00 price target.
American Eagle Outfitters (AEO) — BMO Capital Markets raised its price target to $20.00 from $18.00 and maintained its Market Perform rating.
Amprius Technologies (AMPX) — HC Wainwright reiterated its Buy rating and set an $18.00 price target.
Amprius Technologies (AMPX) — National Bank Financial set an $18.00 price target.
Apple (AAPL) — Morgan Stanley reiterated its Overweight rating.
Apyx Medical (APYX) — Maxim Group initiated coverage with a Buy rating and set a $6.00 price target.
Arbor Realty Trust (ABR) — Citizens Jmp downgraded the stock from Outperform to Market Perform.
Argan (AGX) — JPMorgan lowered its price target to $785.00 from $800.00 and maintained its Overweight rating.
Array Tech (ARRY) — Jefferies resumed coverage with a Buy rating and set a $7 price target.
Atlas Energy Solutions (AESI) — Scotiabank initiated coverage with a Sector Outperform rating and set a $14.00 price target.
AutoZone (AZO) — Morgan Stanley downgraded the stock from Overweight to Market Perform.
AutoZone (AZO) — Sanford C. Bernstein initiated coverage with an Outperform rating and set a $3,698.00 price target.
AxoGen (AXGN) — Morgan Stanley downgraded the stock to Hold.
Axsome Therapeutics (AXSM) — Deutsche Bank lowered its price target to $267.00 from $280.00 and maintained its Buy rating.
Baker Hughes (BKR) — Jefferies lowered its price target to $77.00 from $80.00 and maintained its Buy rating.
Baker Hughes (BKR) — Goldman Sachs Group reiterated its Buy rating and set a $71.00 price target.
Blackrock Tcp Capital (TCPC) — Wells Fargo & Company upgraded the stock from Underweight to Equal Weight, with a price target of $4.00 (from $3.50).
Bloom Energy (BE) — Jefferies raised its price target to $264.00 from $229.00 and maintained its Hold rating.
Bloomin’ Brands (BLMN) — JPMorgan upgraded the stock from Underweight to Neutral, with a price target of $13.00 (from $6.00).
Bloomin’ Brands (BLMN) — Veritas Investment Research set a $13.00 price target.
Boeing (BA) — UBS Group reiterated its Buy rating.
Boot Barn (BOOT) — Craig Hallum lowered its price target to $224.00 from $235.00 and maintained its Buy rating.
Boot Barn (BOOT) — Robert W. Baird lowered its price target to $160.00 from $212.00 and maintained its Outperform rating.
Bruker (BRKR) — Leerink Partners raised its price target to $80.00 from $60.00 and maintained its Outperform rating.
Bullish (BLSH) — Keefe, Bruyette & Woods lowered its price target to $40.00 from $55.00 and maintained its Market Perform rating.
Butterfly Network (BFLY) — Evercore initiated coverage with an Outperform rating and set a $15.00 price target.
C&F Financial Corporation (CFFI) — DA Davidson initiated coverage with a Buy rating and set a $115 price target.
C3.ai (AI) — Citizens Jmp reiterated its Market Perform rating.
Cable One (CABO) — BNP Paribas Exane lowered its price target to $13.00 from $40.00 and maintained its Neutral rating.
CAMP4 Therapeutics (CAMP) — Cantor Fitzgerald reiterated its Overweight rating.
CAMP4 Therapeutics (CAMP) — Chardan Capital lowered its price target to $6.00 from $6.50 and maintained its Buy rating.
Carlyle Secured Lending (CGBD) — Wells Fargo & Company downgraded the stock from Overweight to Equal Weight, with a price target of $11.00 (from $12.00).
Cartesian Therapeutics (RNAC) — Needham & Company reiterated its Buy rating and set a $40.00 price target.
Carvana (CVNA) — Jefferies set a $88.00 price target and maintained its Buy rating.
Centuri (CTRI) — Robert W. Baird lowered its price target to $26.00 from $33.00 and maintained its Outperform rating.
Chemung Financial (CHMG) — DA Davidson initiated coverage with a Buy rating and set a $95 price target.
Chewy (CHWY) — Mizuho lowered its price target to $28.00 from $32.00 and maintained its Outperform rating.
Chipotle Mexican Grill (CMG) — JPMorgan lowered its price target to $37.00 from $40.00 and maintained its Overweight rating.
Choice Hotels International (CHH) — Robert W. Baird lowered its price target to $128.00 from $129.00 and maintained its Outperform rating.
Cintas (CTAS) — Argus raised its price target to $240.00 from $230.00 and maintained its Buy rating.
Circle Internet Group (CRCL) — Susquehanna reiterated its Neutral rating.
Coastal Financial (CCB) — TD Cowen reiterated its Buy rating.
Comcast (CMCSA) — Barclays set its price target to $24.00 from $26.00 and maintained its Equal Weight rating.
Conagra Brands (CAG) — Evercore set a $13.00 price target.
Damora Therapeutics, Inc. Common Stock (DMRA) — Wedbush reiterated its Outperform rating and set a $40.00 price target.
Dell Technologies (DELL) — Susquehanna reiterated its Positive rating.
Dell Technologies (DELL) — TD Cowen raised its price target to $550.00 from $500.00 and maintained its Hold rating.
Deluxe (DLX) — Barrington Research initiated coverage with an Outperform rating and set a $31.00 price target.
Digital Turbine (APPS) — TD Cowen reiterated its Hold rating.
Dollar Tree (DLTR) — Evercore set a $135.00 price target.
Domino’s Pizza (DPZ) — JPMorgan lowered its price target to $350.00 from $380.00 and maintained its Overweight rating.
Donaldson (DCI) — Morgan Stanley set its price target to $95.00 from $91.00 and maintained its Equal Weight rating.
Doximity (DOCS) — Evercore set a $35.00 price target.
Dr. Reddy’s Laboratories (RDY) — Citigroup upgraded the stock from Sell to Buy.
Draganfly (DPRO) — Needham & Company reiterated its Buy rating.
DTE Energy (DTE) — BMO Capital Markets lowered its price target to $132.00 from $143.00 and maintained its Market Perform rating.
Duolingo (DUOL) — DA Davidson reiterated its Buy rating and set a $175.00 price target.
Dutch Bros (BROS) — Jefferies lowered its price target to $60.00 from $75.00 and maintained its Overweight rating.
Dutch Bros (BROS) — JPMorgan lowered its price target to $60.00 from $75.00 and maintained its Overweight rating.
Dyne Therapeutics (DYN) — Piper Sandler set a $47.00 price target.
Empery Digital (EMPD) — Lake Street Capital initiated coverage with a Buy rating and set a $6.00 price target.
EQT (EQT) — Jefferies lowered its price target to $73.00 from $75.00 and maintained its Buy rating.
Equifax (EFX) — Goldman Sachs Group reiterated its Neutral rating and set a $171.00 price target.
Expeditors International of Washington (EXPD) — Barclays raised its price target to $165.00 from $160.00 and maintained its Underweight rating.
Fair Isaac (FICO) — Huber Research downgraded the stock to Underweight.
Fair Isaac (FICO) — Goldman Sachs Group set a $1,322.00 price target.
FedEx (FDX) — Bank of America reiterated its Buy rating and set a $140.00 price target.
FedEx Freight (FDXF) — Bank of America lowered its price target to $140.00 from $157.00 and maintained its Buy rating.
Fidelity National Information Services (FIS) — Deutsche Bank lowered its price target to $40.00 from $45.00 and maintained its Hold rating.
First Commonwealth (FCF) — DA Davidson initiated coverage with a Neutral rating and set a $24 price target.
Five Below (FIVE) — Evercore set a $250.00 price target.
Floor & Decor (FND) — Evercore set a $55.00 price target.
Fortis (FTS) — Barclays lowered its price target to $56.00 from $60.00 and maintained its Overweight rating.
Fresenius Medical Care AG & Co. KGaA (FMS) — Berenberg Bank downgraded the stock from Buy to Hold. and set a $24.00 price target.
FS KKR Capital (FSK) — Wells Fargo & Company downgraded the stock from Sector Perform to Underweight and set a $10.00 price target.
FTAI Infrastructure (FIP) — Citigroup reiterated its Market Outperform rating.
FTAI Infrastructure (FIP) — Jefferies set a $10.00 price target.
FuelCell Energy (FCEL) — Oppenheimer initiated coverage with an Outperform rating and set a $24.00 price target.
H. B. Fuller (FUL) — Deutsche Bank lowered its price target to $62.00 from $72.00 and maintained its Buy rating.
Hinge Health (HNGE) — Bank of America resumed coverage with a Buy rating and set a $110 price target.
Hyliion (HYLN) — Craig Hallum initiated coverage with a Buy rating and set a $7 price target.
Illumina (ILMN) — Leerink Partners raised its price target to $300.00 from $220.00 and maintained its Outperform rating.
Immix Biopharma (IMMX) — Needham & Company raised its price target to $30.00 from $21.00 and maintained its Buy rating.
Inspired Entertainment (INSE) — BWS Financial downgraded the stock from Buy to Neutral.
Iovance Biotherapeutics (IOVA) — HC Wainwright raised its price target to $20.00 from $9.00 and maintained its Buy rating.
IQVIA (IQV) — Royal Bank of Canada raised its price target to $319.00 from $247.00 and maintained its Outperform rating.
IREN (IREN) — B. Riley Financial lowered its price target to $91.00 from $96.00 and maintained its Buy rating.
Jefferies Financial Group (JEF) — BMO Capital Markets lowered its price target to $50.00 from $57.00 and maintained its Market Perform rating.
Jefferies Financial Group (JEF) — Capital One Financial set a $50.00 price target.
Jefferies Financial Group (JEF) — Morgan Stanley lowered its price target to $49.00 from $50.00 and maintained its Equal Weight rating.
Jefferies Financial Group (JEF) — Oppenheimer lowered its price target to $71.00 from $76.00 and maintained its Outperform rating.
Jefferies Financial Group (JEF) — Goldman Sachs Group lowered its price target to $57.00 from $67.00 and maintained its Buy rating.
Jersey Mike’s (JMKE) — Jefferies lowered its price target to $24.00 from $26.00 and maintained its Overweight rating.
Jersey Mike’s (JMKE) — JPMorgan lowered its price target to $24.00 from $26.00 and maintained its Overweight rating.
Jersey Mike’s (JMKE) — UBS Group reiterated its Overweight rating and set a $24.00 price target.
Johnson & Johnson (JNJ) — Bank of America reiterated its Neutral rating and set a $278.00 price target.
Johnson & Johnson (JNJ) — JPMorgan raised its price target to $285.00 from $270.00 and maintained its Neutral rating.
Kimco Realty (KIM) — Morgan Stanley raised its price target to $25.00 from $24.00 and maintained its Equal Weight rating.
Kroger (KR) — Melius Research upgraded the stock from Hold to Buy and set a $80.00 price target.
Liberty Energy (LBRT) — Scotiabank initiated coverage with a Sector Perform rating and set a $19.00 price target.
Liberty Media Corporation – Liberty Formula One Series C (FWONK) — Wells Fargo & Company lowered its price target to $96.00 from $105.00 and maintained its Equal Weight rating.
Life360 (LIF) — DA Davidson reiterated its Neutral rating and set a $40.00 price target.
Lifecore Biomedical (LFCR) — Barrington Research lowered its rating from Outperform to Market Perform.
Mach Natural Resources (MNR) — Raymond James Financial reiterated its Strong-Buy rating and set a $16.00 price target.
Main Street Capital (MAIN) — Wells Fargo & Company upgraded the stock from Equal Weight to Overweight, with a price target of $60.00 (from $55.00).
McDonald’s (MCD) — Jefferies lowered its price target to $250.00 from $260.00 and maintained its Overweight rating.
MediciNova (MNOV) — HC Wainwright reiterated its Buy rating.
Merck & Co., Inc. (MRK) — Scotiabank raised its price target to $180.00 from $155.00 and maintained its Sector Outperform rating.
Merit Medical Systems (MMSI) — Needham & Company reiterated its Buy rating and set a $101.00 price target.
Mid-America Apartment Communities (MAA) — KeyCorp reiterated its Overweight rating.
Mirum Pharmaceuticals (MIRM) — Robert W. Baird raised its price target to $130.00 from $123.00 and maintained its Outperform rating.
Modine Manufacturing (MOD) — DA Davidson reiterated its Buy rating and set a $330.00 price target.
monday.com (MNDY) — JPMorgan downgraded the stock from Overweight to Neutral, with a price target of $87.00 (from $90.00).
MongoDB (MDB) — DA Davidson reiterated its Buy rating and set a $465.00 price target.
MongoDB (MDB) — Guggenheim reiterated its Buy rating.
MongoDB (MDB) — Mizuho set a $460.00 price target.
MSCI (MSCI) — Wells Fargo & Company lowered its price target to $685.00 from $690.00 and maintained its Overweight rating.
Murphy Oil (MUR) — Wells Fargo & Company raised its price target to $43.00 from $42.00 and maintained its Equal Weight rating.
National Energy Services Reunited (NESR) — UBS Group set a $46.00 price target.
Nautilus Biotechnology (NAUT) — Roth Capital initiated coverage with a Buy rating and set a $3.50 price target.
Navitas Semiconductor (NVTS) — Rosenblatt Securities reiterated its Neutral rating and set a $13.00 price target.
NCR Voyix (VYX) — Needham & Company reiterated its Buy rating and set a $14.00 price target.
Netflix (NFLX) — Deutsche Bank upgraded the stock from Hold to Buy, with a price target of $95.00 (from $100.00).
Netflix (NFLX) — TD Cowen initiated coverage with a Buy rating.
New Era Energy & Digital (NUAI) — B. Riley Financial raised its price target to $13.00 from $10.00 and maintained its Buy rating.
NexPoint Residential Trust (NXRT) — Truist Financial set an $18.00 price target.
NIKE (NKE) — Raymond James Financial reiterated its Market Perform rating.
NIKE (NKE) — Royal Bank of Canada lowered its price target to $40.00 from $45.00 and maintained its Sector Perform rating.
NiSource (NI) — Scotiabank initiated coverage with a Sector Perform rating and set a $43.00 price target.
Novo Nordisk A/S (NVO) — BMO Capital Markets reiterated its Market Perform rating.
NVIDIA (NVDA) — Rosenblatt Securities reiterated its Buy rating and set a $390.00 price target.
O’Reilly Automotive (ORLY) — Sanford C. Bernstein initiated coverage with a Market Perform rating and set a $94.00 price target.
Ocular Therapeutix (OCUL) — Needham & Company reiterated its Buy rating and set an $18.00 price target.
Ocular Therapeutix (OCUL) — Royal Bank of Canada reiterated its Outperform rating.
OGE Energy (OGE) — Scotiabank initiated coverage with a Sector Outperform rating and set a $49.00 price target.
Okta (OKTA) — Morgan Stanley raised its price target to $245.00 from $200.00 and maintained its Overweight rating.
ONE Gas (OGS) — Scotiabank initiated coverage with a Sector Outperform rating and set a $86.00 price target.
OptimizeRx (OPRX) — B. Riley Financial resumed coverage with a Buy rating, with a price target of $11.00 (from $10.00).
Paycom Software (PAYC) — Bank of America initiated coverage with an Underperform rating and set a $200.00 price target.
Paylocity (PCTY) — UBS Group set a $175.00 price target.
PepsiCo (PEP) — Jefferies set a $138.00 price target.
PepsiCo (PEP) — JPMorgan downgraded the stock from Overweight to Neutral, with a price target of $138.00 (from $170.00).
Perimeter Solutions (PRM) — UBS Group set a $38.00 price target.
Perimeter Solutions (PRM) — UBS Group reiterated its Buy rating.
Pershing Square (PS) — JonesTrading lowered its rating from Buy to Hold.
Pinnacle West Capital (PNW) — Scotiabank initiated coverage with a Sector Outperform rating and set a $104.00 price target.
Plug Power (PLUG) — HC Wainwright reiterated its Buy rating and set a $7.00 price target.
PPL (PPL) — Scotiabank initiated coverage with a Sector Outperform rating and set a $36.00 price target.
Primoris Services (PRIM) — Cantor Fitzgerald reiterated its Neutral rating and set a $105.00 price target.
ProPetro (PUMP) — Scotiabank initiated coverage with a Sector Perform rating and set a $12.00 price target.
Pyxis Tankers (PXS) — Alliance Global Partners reiterated its Buy rating.
Quantum-Si (QSI) — HC Wainwright reiterated its Buy rating and set a $4.00 price target.
Quince Therapeutics (QNCX) — Citigroup reiterated its Market Outperform rating.
Rapid Micro Biosystems (RPID) — Roth Capital initiated coverage with a Buy rating and set a $3.00 price target.
Regeneron Pharmaceuticals (REGN) — Royal Bank of Canada reiterated its Sector Perform rating and set a $737.00 price target.
Rentokil Initial (RTO) — Morgan Stanley downgraded the stock from Overweight to Equal Weight.
Repligen (RGEN) — UBS Group reiterated its Buy rating.
Restaurant Brands International (QSR) — Jefferies lowered its price target to $78.00 from $82.00 and maintained its Overweight rating.
Restaurant Brands International (QSR) — JPMorgan lowered its price target to $78.00 from $82.00 and maintained its Overweight rating.
Rezolute (RZLT) — Craig Hallum upgraded the stock from Hold to Buy, with a price target of $7.00 (from $4.00).
Robinhood Markets (HOOD) — Barclays Capital reiterated its Overweight rating.
Robinhood Markets (HOOD) — BTIG Research raised its price target to $135.00 from $125.00 and maintained its Buy rating.
Robinhood Markets (HOOD) — Deutsche Bank lowered its price target to $134.00 from $138.00 and maintained its Buy rating.
Robinhood Markets (HOOD) — Keefe, Bruyette & Woods raised its price target to $115.00 from $100.00 and maintained its Market Perform rating.
Robinhood Markets (HOOD) — Loop Capital set a $135.00 price target.
Robinhood Markets (HOOD) — Morgan Stanley downgraded the stock from Overweight to Outperform.
Rollins (ROL) — BNP Paribas Exane lowered its price target to $35.00 from $44.00 and maintained its Neutral rating.
Rollins (ROL) — Morgan Stanley lowered its price target to $45.00 from $60.00 and maintained its Overweight rating.
Rollins (ROL) — Wells Fargo & Company reiterated its Underweight rating, with a price target of $27.00 (from $32.00).
Ryder System (R) — Robert W. Baird downgraded the stock from Outperform to Neutral, with a price target of $245.00 (from $290.00).
Sangoma Technologies (SANG) — TD Securities downgraded the stock from Buy to Sell.
Scotts Miracle-Gro (SMG) — Stifel lowered its price target to $75.00 from $76.00 and maintained its Buy rating.
Sempra Energy (SRE) — Scotiabank initiated coverage with a Sector Perform rating and set a $83.00 price target.
Shake Shack (SHAK) — JPMorgan lowered its price target to $75.00 from $77.00 and maintained its Neutral rating.
Shore Bancshares (SHBI) — DA Davidson initiated coverage with a Neutral rating and set a $25 price target.
Southwest Gas (SWX) — Scotiabank initiated coverage with a Sector Outperform rating and set a $95.00 price target.
SpaceX (SPCX) — Morgan Stanley reiterated its Overweight rating.
SpaceX (SPCX) — TD Cowen initiated coverage with a Buy rating and set a $200 price target.
SpaceX (SPCX) — Goldman Sachs Group reiterated its Buy rating.
SpaceX (SPCX) — UBS Group reiterated its Buy rating.
Spire (SR) — Scotiabank initiated coverage with a Sector Perform rating and set a $79.00 price target.
SPX Technologies (SPXC) — Vertical Research initiated coverage with a Buy rating and set a $215 price target.
STAAR Surgical (STAA) — Stifel upgraded the stock from Hold to Buy, with a price target of $31.00 (from $28.00).
STAAR Surgical (STAA) — Veritas Investment Research set a $31.00 price target.
Starbucks (SBUX) — JPMorgan lowered its price target to $105.00 from $112.00 and maintained its Overweight rating.
Stitch Fix (SFIX) — Mizuho upgraded the stock from Underperform to Neutral, with a price target of $2.50 (from $3.00).
Summit Therapeutics (SMMT) — Jefferies reiterated its Buy rating and set a $30.00 price target.
Summit Therapeutics (SMMT) — Morgan Stanley downgraded the stock to Outperform.
Summit Therapeutics (SMMT) — Goldman Sachs Group set a $41.00 price target and maintained its Buy rating.
Sweetgreen (SG) — Royal Bank of Canada raised its price target to $11.00 from $6.50 and maintained its Outperform rating.
Syndax Pharmaceuticals (SNDX) — Jefferies reiterated its Buy rating and set a $35.00 price target.
Sysco (SYY) — JPMorgan lowered its price target to $95.00 from $100.00 and maintained its Overweight rating.
T-Mobile US (TMUS) — Barclays lowered its price target to $200.00 from $215.00 and maintained its Overweight rating.
Texas Roadhouse (TXRH) — JPMorgan lowered its price target to $200.00 from $202.00 and maintained its Neutral rating.
TransUnion (TRU) — Goldman Sachs Group lowered its price target to $77.00 from $89.00 and maintained its Neutral rating.
Twist Bioscience (TWST) — Leerink Partners raised its price target to $190.00 from $160.00 and maintained its Outperform rating.
Ubiquiti (UI) — BWS Financial reiterated its Buy rating and set a $980.00 price target.
UGI (UGI) — Scotiabank initiated coverage with an Outperform rating and set a $46.00 price target.
Unicycive Therapeutics (UNCY) — HC Wainwright lowered its price target to $13.00 from $15.00 and maintained its Buy rating.
Uniti Group (UNIT) — Raymond James Financial set a $16.00 price target and maintained its Strong-Buy rating.
US Foods (USFD) — JPMorgan lowered its price target to $98.00 from $108.00 and maintained its Neutral rating.
Vail Resorts (MTN) — Barclays Capital lowered its price target to $117.00 from $119.00 and maintained its Underweight rating.
Vail Resorts (MTN) — Deutsche Bank lowered its price target to $132.00 from $138.00 and maintained its Hold rating.
Vail Resorts (MTN) — Jefferies reiterated its Buy rating and set a $162.00 price target.
Vail Resorts (MTN) — JPMorgan raised its price target to $150.00 from $126.00 and maintained its Neutral rating.
Vail Resorts (MTN) — Mizuho lowered its price target to $156.00 from $160.00 and maintained its Outperform rating.
Vail Resorts (MTN) — Stifel Nicolaus set its price target to $157.00 from $161.00 and maintained its Buy rating.
Vail Resorts (MTN) — Truist Financial lowered its price target to $191.00 from $195.00 and maintained its Buy rating.
Vail Resorts (MTN) — Wells Fargo & Company raised its price target to $130.00 from $125.00 and maintained its Equal Weight rating.
Vale (VALE) — UBS Group reiterated its Neutral rating.
Valley National Bancorp (VLY) — Royal Bank of Canada reiterated its Outperform rating and set a $17.00 price target.
VEON (VEON) — Northland Securities set an $85.00 price target.
Victoria’s Secret & Co. (VSXY) — Wells Fargo & Company raised its price target to $100.00 from $90.00 and maintained its Overweight rating.
Walmart (WMT) — Mizuho lowered its price target to $125.00 from $130.00 and maintained its Outperform rating.
Warner Bros. Discovery (WBD) — Argus downgraded the stock from Hold to Sell.
Warner Music Group (WMG) — Guggenheim reiterated its Buy rating and set a $36.00 price target.
Wayfair (W) — Mizuho raised its price target to $110.00 from $90.00 and maintained its Outperform rating.
Western Union (WU) — Cantor Fitzgerald lowered its price target to $6.00 from $7.00 and maintained its Underweight rating.
Xanadu Quantum Technologies Inc. (XNDU) — RBC Capital Markets initiated coverage with an Outperform rating and set a $16 price target.
Xcel Energy (XEL) — Scotiabank initiated coverage with a Sector Outperform rating and set a $77.00 price target.
XP (XP) — Citigroup reiterated its Buy rating.
XPENG (XPEV) — JPMorgan downgraded the stock from Overweight to Neutral, with a price target of $11.50 (from $24.00).
Yum! Brands (YUM) — JPMorgan lowered its price target to $150.00 from $160.00 and maintained its Overweight rating.
Zscaler (ZS) — Barclays Capital raised its price target to $220.00 from $200.00 and maintained its Overweight rating.
Zymeworks (ZYME) — Citigroup reiterated its Buy rating.
Zymeworks (ZYME) — TD Cowen initiated coverage with a Buy rating and set a $34.00 price target.
More Ratings:
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.